Novo Nordisk’s Tresiba Insulin Fails to Win FDA Approval

Novo Nordisk’s Tresiba Insulin Fails to Win FDA Approval

Anders Boggild/Novo Nordisk via Bloomberg

An employee holds oral insulin pills, produced by Novo Nordisk A/S, at the company's research and development unit in Malov.